Le Lézard
Classified in: Health
Subject: TRI

UMF|PerfectCLEAN's KLORESEtm Disinfectant and PerfectCLEAN Wiper Eliminate C. auris in Less Than One Minute


Powerful combination of KLORESE and PerfectCLEAN wiper is essential in the battle against deadly fungal infections

NORTHBROOK, Ill., April 30, 2024 /PRNewswire/ -- Independent testing shows that UMF|PerfectCLEAN's KLORESEtm cleaner-disinfectant combined with a PerfectCLEAN wiper eliminates the deadly fungus Candida auris (C. auris) in less than one minute. Performed by leading contract services organization Integrated Pharma Services, the testing is further proof that KLORESE and PerfectCLEAN are the perfect combination for cleaning and disinfecting any surface in a healthcare facility.

C. auris on the rise in healthcare
Research indicates that a rise in severe fungal infections such as C. auris has resulted in more than 150 million cases annually and almost 1.7 million fatalities globally. According to the World Health Organization (WHO), multi-drug resistant Candida species including C. auris cause many preventable healthcare-associated infections (pHAIs).

Recognizing such fungal infections as a widespread threat to the entire healthcare system, the WHO issued a call to action for the healthcare community to protect people from such fungi. Cleaning and disinfecting patient care environments are primary infection control measures for preventing the transmission of C. auris in healthcare settings.

KLORESE + PerfectCLEAN: A powerful combination for eliminating C. auris
"Our testing results demonstrated that a PerfectCLEAN wiper combined with KLORESE, an EPA-registered cleaner-disinfectant, is capable of complete removal of C. auris from surfaces, retaining it in the wiper where it is exposed to KLORESE, which eliminated 100% of the C. auris in one minute or less," said Dr. Mina Izadjoo, president and chief science officer at Integrated Pharma Services.

KLORESE and a PerfectCLEAN wiper help eliminate and prevent C. auris by:

"The result of this testing further validates KLORESE combined with PerfectCLEAN wipers as essential in the fight against pHAIs such as C. auris," said UMF|PerfectCLEAN CEO George Clarke. "With this powerful combination, Environmental Services teams can safely, effectively, and efficiently clean and disinfect surfaces throughout the healthcare facility. KLORESE and the PerfectCLEAN wiper are the only tools required to clean and disinfect any surface in any room."

Added Clarke, "While patient health and safety is the utmost priority, the cost to treat C. auris and other pHAIs is considerable due to extended hospital stays, intensive care, diagnostic tests, and expensive medications. Effective environmental cleaning and disinfection help mitigate such costs by mitigating the risk of such infections."

Reach out to learn how KLORESE and PerfectCLEAN can help your organization eliminate and prevent pHAIs such as C. auris.

About UMF|PerfectCLEAN
UMF|PerfectCLEAN is the leader in the research and development of high-performance products, programs, and training for the infection prevention and commercial cleaning markets. Through extensive testing, exhaustive analysis, and the commitment of significant human and financial resources, UMF|PerfectCLEAN has merged new technologies with innovative product designs that are reinventing cleantm. UMF|PerfectCLEAN is a proud strategic partner of the Association for Professionals in Infection Control and Epidemiology (APIC). LinkedIn

SOURCE UMF Corporation


These press releases may also interest you

at 19:42
The shareholders in Immunovia AB (publ), Reg. No. 556730-4299, are hereby invited to the Annual General Meeting ("AGM") to be held at The Spark, Scheeletorget 1, Medicon Village, in Lund on Wednesday 19 June 2024 at 10 a.m. CEST. Right to...

at 18:54
The Board of Directors of Immunovia AB (publ) ("Immunovia" or the "Company") has today,...

at 18:12
The global functional food ingredients market size is estimated to grow by USD 53.14 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of almost 7.38% during the forecast period. ...

at 17:55
City of Hope®, one of the largest cancer research and treatment organizations in the United States, has been awarded $5.4 million from the California Institute for Regenerative Medicine (CIRM) to build and fund a stem cell research laboratory on its...

at 17:25
Talphera, Inc. , ("Talphera"), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced that the Board of Directors of Talphera has granted...

at 16:56
A paper published in the June edition of the Journal Diabetes demonstrates that C-peptide, a biomarker that indicates the production of insulin, is a validated surrogate endpoint, or predictor of clinical benefit, for clinical trials of...



News published on and distributed by: